DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
34 hedge funds and large institutions have $988K invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
Holders
34
Holders Change
+1
Holders Change %
+3.03%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
4
Closed
2
Calls
$40K
Puts
–
Net Calls
+$40K
Net Calls Change
-$45K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$151K |
| 2 |
CAC
2
Cowen and Company
New York
|
$97.7K |
| 3 |
3
Walleye Capital
New York
|
$173K |
| 4 |
WAM
4
Wolverine Asset Management
Chicago,
Illinois
|
$4.94K |
| 5 |
SC
5
Shay Capital
New York
|
$13.4K |
